Cyclolignans as inhibitors of the insulin-like growth factor-I receptor

被引：7
作者：
Larsson, Olle [1 ]
Axelson, Magnus
机构：
[1] Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden
[2] Karolinska Hosp, Dept Clin Chem, S-10401 Stockholm, Sweden
来源：
CANCER RESEARCH | 2007年 / 67卷 / 06期
关键词：
D O I：
10.1158/0008-5472.CAN-06-3659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2899 / 2900
页数：2
相关论文
共 5 条
  • [1] DESBENE S, 2002, CURR MED CHEM ANTICA, V22, P71
  • [2] Dupont J, 2003, HORM METAB RES, V35, P740
  • [3] Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
    Girnita, A
    Girnita, L
    del Prete, F
    Bartolazzi, A
    Larsson, O
    Axelson, M
    [J]. CANCER RESEARCH, 2004, 64 (01) : 236 - 242
  • [4] Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
    Menu, E
    Jernberg-Wiklund, H
    Stromberg, T
    De Raeve, H
    Girnita, L
    Larsson, O
    Axelson, M
    Asosingh, K
    Nilsson, K
    Van Camp, B
    Vanderkerken, K
    [J]. BLOOD, 2006, 107 (02) : 655 - 660
  • [5] IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-)
    Rosengren, Linda
    Vasilcanu, Daiana
    Vasilcanu, Radu
    Fickenscher, Sandra
    Sehat, Bita
    Natalishvili, Nathalia
    Naughton, Sean
    Yin, Shucheng
    Girnita, Ada
    Girnita, Leonard
    Axelson, Magnus
    Larsson, Olle
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (04) : 1059 - 1066
1